DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal
DexCom receives FDA clearance for DexCom Smart Basal titration software module, which optimizes basal insulin dose in type 2 diabetes patients by integrating with the G7 15 day sensor.
Wall Street Analysts Believe Masimo ( MASI ) Could Rally 26.6%: Here's is How to Trade
The mean of analysts' price targets for Masimo (MASI) points to a 26.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
What's Going On With Apple Stock Today? - Apple ( NASDAQ:AAPL )
Shares of Apple Inc. ( NASDAQ:AAPL ) are falling Monday. Here's a look at what investors need to know. AAPL is under selling pressure. Get the details here.
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Adverum Biotechnologies ( NASDAQ:ADVM ) , Alto Neuroscience ( NYSE:ANRO )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Apple Ordered To Pay Over $600 Million In Smartwatch Patent Case Against Masimo - Masimo ( NASDAQ:MASI )
A federal jury in California has ruled that Apple Inc. ( NASDAQ:AAPL ) must pay Masimo Corporation ( NASDAQ:MASI ) $634 million for infringing a patent related to blood-oxygen reading technology. The jury on Friday found Apple guilty of infringing a patent held by Masimo, a ...
4D Advisors Offloads $7.6 Million in Masimo ( MASI ) Stock, Selling 45,000 Shares
On Nov. 14, 2025, 4D Advisors, LLC disclosed in a regulatory filing that it sold out its entire position in Masimo ( NASDAQ:MASI ) . The sale was valued at $7.57 million.According to a filing with the Securities and Exchange Commission dated November 14, 2025, 4D Advisors, LLC reported selling ...
3 Reasons Growth Investors Will Love Masimo ( MASI )
Masimo (MASI) possesses solid growth attributes, which could help it handily outperform the market.
Masimo ( MASI ) Upgraded to Buy: Here's What You Should Know
Masimo (MASI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why Masimo ( MASI ) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand
Masimo beats third-quarter 2025 earnings and revenue estimates as operating margins and profits improve on lower expenses.
Masimo ( MASI ) Q3 Earnings and Revenues Top Estimates
Masimo (MASI) delivered earnings and revenue surprises of +10.92% and +1.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $133B Cardiac Diagnostics Market
Designed for investors, board members, and CEOs, the latest PatentVest Pulse report offers a strategic view of who's leading and why in the rapidly evolving cardiac diagnostics market Designed for investors, board members, and CEOs, the latest PatentVest Pulse report offers a strategic view of ...
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.
$1000 Invested In Masimo 10 Years Ago Would Be Worth This Much Today - Masimo ( NASDAQ:MASI )
Masimo ( NASDAQ:MASI ) has outperformed the market over the past 10 years by 1.63% on an annualized basis producing an average annual return of 14.12%. Currently, Masimo has a market capitalization of $8.04 billion.
Here's Why You Should Add OPKO Health Stock to Your Portfolio
OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.
WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit
West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.
GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.
Bet On 5 Top-Ranked Stocks With Rising P/E
Tap these five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks are The Honest Company, Dutch Bros, AIM ImmunoTech, Masimo and Cognizant Technology Solutions.
HIMS Stock Declines Despite Launch of New Specialty in Women's Health
Hims & Hers debuts a new women's health specialty, targeting menopause care with personalized treatment plans.
BDX Launches AI-Enabled Platform to Unify Healthcare Connectivity
BD's new AI-driven Incada Platform and upgraded Pyxis Pro system unite connected care, driving its digital healthcare edge.
Here's Why Masimo ( MASI ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Avantor Partners With BlueWhale Bio to Advance CAR-T Manufacturing
AVTR collaborates with BlueWhale Bio to speed CAR-T manufacturing using CDNP tech, aiming to scale production and expand patient access.
Recent Report Shows That Rep. Kevin Hern Sold Up to $200K Worth of Accenture Stock - Accenture ( NYSE:ACN ) , Home Depot ( NYSE:HD )
October 16, 2025 records indicate that Representative Kevin Hern filed a sale of Accenture ( NYSE:ACN ) , valued between $60,004 and $200,000. According to the October filing, the transaction occurred on September 26, 2025. Currently, Accenture shares are trading up 0.43% at $235.01.
Reasons to Add HealthEquity Stock to Your Portfolio for Now
HQY's strong Q2, expanding HSAs and AI-driven efficiencies highlight its growth momentum despite data security risks.
Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition
MMSI is set to acquire C2 CryoBalloon from Pentax for $22M, strengthening its GI portfolio. Despite near-term dilution, the deal positions Merit for long-term growth in gastroenterology.
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
VEEV's strong Q2, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.
Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now
WST's growth prospects remain strong, fueled by GLP-1 demand and high-value products, though tariffs and execution risks weigh on margins.
STXS Partners With CardioFocus to Boost Robotic Pulsed Field Ablation
Stereotaxis partners with CardioFocus to commercialize the first robotic Pulsed Field Ablation system, aiming to revolutionize cardiac arrhythmia treatment.
BD Stock Down Despite Making Progress in the Treatment of PAD Lesions
BDX advances PAD care with first patient enrolled in the XTRACT Registry using its dual-action Rotarex system.
INSP Shares Down Despite Strong Clinical Data From Inspire V Trials
Inspire Medical's Inspire V system shows strong safety, faster surgeries, and higher patient adherence in new trials.
Pulse Biosciences Unveils Promising First-in-Human Data for nPulse
PLSE unveils strong first-in-human data for its nPulse Cardiac Surgical System, showcasing safety, speed, and durable AF treatment potential.
BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow
BDX teams with Opentrons to automate single-cell sequencing, advancing its multiomics and biosciences strategy.
GE Healthcare Partners With Erasmus to Advance Precision Cancer Care
GEHC's collaboration with Erasmus MC aims to advance precision oncology using next-gen total body PET/CT and AI imaging innovations.
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
PACB's Q2 beat, expanding Revio and Vega systems and growing clinical traction highlight its innovation-led recovery despite longer purchasing cycles.
Ecolab Brings Direct-to-Chip Cooling Monitoring to Southeast Asia
ECL debuts its 3D TRASAR direct-to-chip cooling monitoring in Singapore, boosting efficiency and sustainability in data centers.
OMI Reshapes Portfolio With $375 Million Sale to Platinum Equity
Owens & Minor sharpens its focus on home-based care with a $375M divestiture to Platinum Equity, unlocking cash, tax benefits, and long-term upside through a retained equity stake.
The Launch of Foot and Ankle Trauma Solutions May Boost ZBH Stock
Zimmer Biomet expands its foot & ankle trauma lineup with Gorilla Pilon Fusion & Phantom TTC Trauma Nail launches.
ISRG Shares Rise as FDA Clears AI Integration for Ion Platform
Intuitive Surgical shares climb after FDA clears AI-driven upgrades for its Ion platform, boosting precision and efficiency in lung biopsies.
RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes
Revvity partners with Sanofi to launch a scalable diagnostic test for early T1D detection, expanding its reach beyond rare diseases.
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
ECL's robust product lineup, innovation-driven growth and strong Q2 results underscore its long-term potential despite macroeconomic headwinds.
PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell
PACB expands seqWell partnership to enhance its sequencing workflow offerings with a new multiplexing kit.
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.
Thermo Fisher's New R&D Alliance With AstraZeneca May Lift Its Stock
TMO joins AstraZeneca's BioVentureHub to boost R&D, innovation and life science access.
Reasons to Add Omnicell Stock to Your Portfolio Right Now
OMCL's expanding SaaS portfolio, overseas growth plans, and solid balance sheet position it for sustained momentum despite rising competition.
CAH Expands Distribution Network With Indianapolis Facility
Cardinal Health accelerates its multi-year supply chain transformation with a new flagship Indianapolis distribution center, reinforcing automation-driven efficiency while building on recent logistics expansions in Ohio and Texas.
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
ClearPoint's new Robotic Neuro-Navigation System merges proven software with KUKA robotics to boost precision in cell and gene therapy delivery.
BRKR Shares Climb After Securing New Orders for Its NMR Systems
Bruker stock climbs after securing $10M in federally funded NMR orders from top U.S. research institutions.
Why Masimo ( MASI ) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is the Options Market Predicting a Spike in Masimo Stock?
Investors need to pay close attention to MASI stock based on the movements in the options market lately.
ILMN Stock Set to Benefit From the Launch of New BioInsight Division
Illumina launches BioInsight to harness multiomic data, accelerate drug discovery, and boost disease diagnosis.
